From Mechanism to Market

For 20 years Rosa has delivered insights to our clients that would be impossible to obtain in any other way.

PhysioPD Research

PhysioPD™ Research is a proprietary approach that translates the physiology, disease pathophysiology, and drug pharmacology of interest into a customized and interactive mathematical Research Platform. PhysioPD delivers credible insights that would be impossible to obtain in any other way. It is used by scientists and clinicians to clarify the connection between disease mechanisms, therapeutic interventions, and clinical outcomes. The result is that decision-makers have a dramatic increase in confidence to develop successful clinical trials and product submissions.

Learn more about PhysioPD Research
PhysioPD Research

Market Modeling

Rosa Market Modeling credibly identifies what product attributes drive physician uptake. Rosa's proprietary methods and technology can explore a breadth of product profiles and competitive scenarios that would be impossible to explore in any other way. The Market Model is a durable asset that can be used to fine-tune product features and demonstrate the potential commercial demand in a variety of current and future competitive scenarios over multiple years.

Learn more about Market Modeling

Explore our Worldwide Webinar Series

Rosa’s "Impact" webinar series is renowned for its informative discussions on the use of computer modeling and simulation within the global research and development community. Register for an upcoming webinar or download a webinar from the archives.

Explore Webinars

Recent Highlights

Rosa & Co. announces the presentation of a poster at the 2021 ICIEM meeting

Rosa & Co. is proud to announce that a poster authored by Rosa scientists will be presented at the upcoming 14th International Congress of Inborn Errors of Metabolism (ICIEM) meeting. Rebecca Baillie, Ph.D, Principal Scientist and Chief of Staff ... Read More

Rosa & Co. announces contributions of Dr. Christina Friedrich to the publication of an article on FDA-Industry Scientific Exchange

Rosa & Co. announced today the contributions of Dr. Christina Friedrich, Chief Engineer at Rosa, to the article titled, “FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meetin... Read More

Webinar showcases how Rosa Market Modeling is used to optimize competitive positioning

Today, Rosa & Co. announced that Dr. Bill Brastow, Chief Technology Officer at Rosa Market Modeling, will present a webinar entitled “Driving Market Share for Healthcare Products by Integrating Market Modeling” on Wednesday, March 18. Hosted in p... Read More

Rosa & Co. announces the presentation of a poster at the 2021 ACoP meeting

Rosa & Co. is proud to announce that a poster authored by Rosa scientists will be presented at the upcoming virtual American Conference on Pharmacometrics (ACoP) meeting.Christina Friedrich, Ph.D., Chief Engineer at Rosa & Co. and Renee Meyer... Read More

"Rosa is all about doing better science"
—Christina Friedrich, PhD, Chief Engineer, PhysioPD
Learn about PhysioPD Research